‘Just the beginning’: UAS Labs agrees to acquire Nebraska Cultures

By Stephen Daniells contact

- Last updated on GMT

© Getty Images / pichet_w
© Getty Images / pichet_w
Wisconsin-based UAS Laboratories LLC has announced the acquisition of Nebraska Cultures, Inc., which specializes in custom-manufactured probiotic solutions including Lactobacillus acidophilus DDS-1 and the ProDURA brand of spore-based probiotics.

Through this transaction, UAS Labs​ will accelerate its leadership in the fast-growing probiotic industry, said UAS in a release.

Kevin Mehring, UAS Labs President and CEO, told NutraIngredients-USA that the acquisition marks the start of an exciting year for UAS Labs. “The acquisition of Nebraska Cultures is just the beginning,”​ he said.

DDS-1

The acquisition gives UAS exclusivity over Lactobacillus acidophilus​ DDS-1, one of the longest studied probiotic strains. Dr. Khem Shahani discovered and began research on the DDS-1 strain of L. acidophilus​ in 1959. Dr. Shahani founded Nebraska Cultures in 1981. Throughout his career, Dr. Shahani published over 200 peer-reviewed scientific articles, many demonstrating the health benefits of DDS-1. UAS Labs has conducted multiple double-blind, gold standard clinical studies on DDS-1 in recognition of the strengths of the strain.

In addition, UAS will now provide spore-based probiotics utilizing the well-established ProDURA brand​. Maypro Industries, a distributor for Nebraska Cultures, will continue to support the ProDURA line with their existing customer base.

Lakeview Equity Partners, LLC​, the majority owner of UAS Labs, lead the acquisition effort. Terms were not disclosed. Mehring confirmed that this was an acquisition of assets, and noted that a few key members of the Nebraska Cultures team will be involved to ensure a successful transition.

“We are extremely proud to have acquired a company that has shown strong values, impressive science and a dedication to the industry,” ​said Mehring. “This groundwork enables our passionate group of colleagues to further our company mission of providing leading and trusted probiotic-based solutions.”

Finding a new home

Michael Shahani, Nebraska Cultures COO, commented: “We are honored to have served the nutraceutical industry for several decades, beginning in the 1950’s with my father’s pioneering research,”​ said “We are thrilled to find in UAS a home where this work can contribute to tomorrow’s industry through the tremendous technical and production capabilities that this company provides.”

Dr. Gregory Leyer, UAS Labs’s CSO, added: “We are honored to have the opportunity to write the next successful chapter for the DDS-1 strain and are grateful for the work that the Shahani family has done to continue their fathers’ life work.”

Related topics: Suppliers

Related news

Follow us

Featured Events

View more

Products

View more

Webinars